Psilocybin provides benefit for people with cancer and major depression, clinical trial reveals

New results from a clinical trial reveal that a single dose of psilocybin—a naturally occurring psychedelic compound found in mushrooms—can provide sustained reductions in depression and anxiety in individuals with cancer suffering from major depressive disorder. The findings are published in Cancer.

Chinese Weather Hackers vs. America 😳🤯
- New Law in England Requires Cat Microchipping or Face £500 Fines - Bertha Stephens
- Regulating AI-generated Voices: The FCC's Stand Against Misleading Robocalls - Sean George
- Rethinking AI: DeepSeek’s playbook shakes up the high-spend, high-compute paradigm - Jae Lee, TwelveLabs
- Understanding the Rabbit R1: A Revolution in the World of AI - Sean George
- How The L.A. Riots Demonstrate Democrat-Media Complex’s Loss Of Narrative Control - Diana Zapata
- Goody-2 is an AI-powered chatbot that is designed to push boundaries when it comes to safety and responsibility. - Sean George

“We Will Kill You” Florida Sheriff Issues BRUTAL Warning to Rioters
- What Do Retinoids Do? Plus, Types and How To Use Them - Laura Schober
- The Hidden Consequences of Melting Arctic Ice - Arya Chandran
- Pros and Cons of Renting Your Car on Turo: What You Should Know - Zoul
- Understanding Formaldehyde: A Carcinogen with a Dual Role in the Body - Arya Chandran
- WME Signs Oscar-Winning Filmmaker Brian Helgeland - matthewgrobar
- Full-screen Xbox handheld UI is coming to all Windows PCs “starting next year” - Andrew Cunningham